ADVERTISEMENT
3 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Finance

COVID-19 forces cuts at chemical maker Ingevity

by Alexander H. Tullo
June 5, 2020 | APPEARED IN VOLUME 98, ISSUE 22

 

The pine chemical maker Ingevity is cutting costs because of the COVID-19 pandemic. It will furlough employees and make workforce reductions through early retirement and other measures. It will also suspend some benefits, including matching contributions for 401(k) retirement plans, and reduce outlays for consulting and other services. “Some of these measures are temporary, but many are permanent,” says interim CEO Rick Kelson. Ingevity doesn’t say how much the measures will save but does say that they will help it remain within its 2020 target of $310 million–$350 million in pretax earnings and $1.1 billion–$1.2 billion in sales.

C&EN has made this story and all of its coverage of the coronavirus epidemic freely available during the outbreak to keep the public informed. To support our journalism, become a member of ACS or sign up for C&EN's weekly newsletter.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment